SUSTAIN focused on tailored integrated care for older people; TO-REACH addressed resilient and equitable health system organization; PROEIPAHA supported the European Innovation Partnership on Active and Healthy Ageing.
EUROPEAN HEALTH MANAGEMENT ASSOCIATION
Brussels-based health management association bridging EU research outcomes with real-world health system adoption and policy implementation.
Their core work
EHMA is a Brussels-based association that brings health management and policy expertise to EU research consortia. They specialize in translating clinical research findings into health system practices — bridging the gap between what researchers discover and how healthcare organizations actually implement change. Their work spans integrated care models, digital health literacy, patient engagement frameworks, and evidence-based health policy. In projects, they typically handle dissemination, policy recommendations, and real-world validation of health interventions across European health systems.
What they specialise in
Across SUSTAIN, TO-REACH, IC-Health, MULTI-ACT, and HEART, EHMA consistently contributes policy translation, dissemination to health managers, and evidence-to-practice transfer.
IC-Health addressed digital health literacy; COVIRNA used AI and biomarkers for COVID-19 prognosis; HEART applies AI-based monitoring for urban health interventions.
REBECCA uses real-world data and wearables for breast cancer-induced chronic conditions; COVIRNA developed patient stratification models — both reflect a shift toward data-driven chronic disease management.
HEART explores blue-green infrastructure impacts on urban health, representing EHMA's expansion into environmental determinants of health.
How they've shifted over time
EHMA's early H2020 work (2015–2018) centered on traditional health management themes: integrated care for older people, digital health literacy, and health system resilience. From 2020 onward, their focus shifted markedly toward data-intensive and technology-driven health topics — AI-based diagnostics (COVIRNA), real-world evidence from wearables (REBECCA), and AI-powered environmental health monitoring (HEART). This evolution shows an association that started with care organization and policy, and is now building capacity in data science applications for health systems.
EHMA is moving from traditional health management toward becoming a policy and dissemination partner for data-intensive, AI-enabled health research — expect them to seek projects combining digital health tools with health system implementation.
How they like to work
EHMA operates exclusively as a participant — they have never coordinated an H2020 project, which is typical for associations whose value lies in network access and policy dissemination rather than research leadership. With 121 unique partners across 30 countries in just 8 projects, they work in large, diverse consortia and rarely repeat partnerships, suggesting they serve as a trusted "health management voice" that different research teams invite for policy credibility. Their average funding per project (EUR 162K) confirms a supporting role focused on dissemination, engagement, and policy work packages.
EHMA has collaborated with 121 unique partners across 30 countries in 8 projects, giving them one of the broader health policy networks among Brussels-based associations. Their reach is pan-European with no strong geographic concentration, reflecting their role as a continental health management network.
What sets them apart
EHMA's distinctive value is that they represent health managers and health system administrators — the people who actually decide whether a research innovation gets adopted in hospitals and clinics. While clinical partners bring medical expertise and universities bring research rigor, EHMA brings the implementation perspective: will this work in a real health system? For consortium builders, adding EHMA signals to evaluators that the project takes real-world uptake seriously, not just publication metrics.
Highlights from their portfolio
- SUSTAINLargest EHMA project by funding (EUR 293K), a flagship integrated care study across multiple European countries that directly aligned with EHMA's core mission.
- REBECCARepresents EHMA's newest direction — combining real-world data, wearables, and causal modelling for breast cancer chronic conditions, with EUR 244K funding showing growing trust in EHMA for data-driven health projects.
- COVIRNAA rapid-response COVID-19 diagnostics project using AI and biomarkers, demonstrating EHMA's ability to pivot into urgent public health challenges with technology-driven approaches.